ArticleFrontiers in molecular biosciences2026
Purification of ribosomes from human embryonic stem (hES) cells for high-resolution Cryo-EM structural studies.
Article in Frontiers in molecular biosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human ribosome structures at near-atomic resolution have been determined predominantly from transformed cell lines, often using translation inhibitors during purification that can introduce structural artifacts. We present a robust and scalable protocol for purifying 80S ribosomes from human embryonic stem (hES) cell cultures. The method addresses two common bottlenecks for structural studies of ribosomes from pluripotent cells: limited starting material and structural perturbations introduced by translation inhibitors such as cycloheximide or anisomycin. By combining gentle lysis and rapid clarification with a sucrose-cushion concentration step followed by gradient based purification the workflow preserves native ribosome conformations and yields highly pure 80S ribosomes suitable for single-particle cryo-EM at near-atomic resolution model building. The workflow was reproduced across independent preparations with consistent yields and map quality. As expected for inhibitor-free purification, no density corresponding to elongation inhibitors was observed in ribosomal functional centers. We supply a detailed, scalable protocol that includes buffer recipes, expected yields, quality control and troubleshooting steps, and recommendations for cryo-EM grid preparation. The procedure is transferable to other sensitive cell types (for example, primary B cells and iPS cells). This workflow expands access to native human ribosomes from non-transformed, developmentally relevant cells for structural and mechanistic studies of translation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.